Wolfgang Bernhard1, Katrin Böckmann2, Christoph Maas2, Michaela Mathes2, Julia Hövelmann2, Anna Shunova2, Verena Hund3, Erwin Schleicher4, Christian F Poets2, Axel R Franz2,5. 1. Department of Neonatology, University Hospital, Calwerstr. 7, 72076, Tübingen, Germany. wolfgang.bernhard@med.uni-tuebingen.de. 2. Department of Neonatology, University Hospital, Calwerstr. 7, 72076, Tübingen, Germany. 3. University Pharmacy Department, Eberhard-Karls-University, Tübingen, Germany. 4. Department of Internal Medicine IV, Eberhard-Karls-University, Tübingen, Germany. 5. Center for Pediatric Clinical Studies, University Children's Hospital, Tübingen, Germany.
Abstract
OBJECTIVE:Choline and docosahexaenoic acid (DHA) are essential nutrients for preterm infant development. They are metabolically linked via phosphatidylcholine (PC), a constitutive plasma membrane lipid and the major transport form of DHA in plasma. Plasma choline and DHA-PC concentrations rapidly decline after preterm birth. To improve preterm infant nutrition, we evaluated combined compared to exclusive choline and DHA supplementation, and standard feeding. DESIGN: Randomized partially blinded single-center trial. SETTING:Neonatal tertiary referral center in Tübingen, Germany. PATIENTS: 24 inborn preterm infants < 32 week postmenstrual age. INTERVENTIONS:Standard nutrition (control) or, additionally, enteral choline (30 mg/kg/day), DHA (60 mg/kg/day), or both for 10 days. Single enteral administration of 3.6 mg/kg [methyl-D9-] choline chloride as a tracer at 7.5 days. MAIN OUTCOME MEASURES: Primary outcome variable was plasma choline following 7 days of supplementation. Deuterated and unlabeled choline metabolites, DHA-PC, and other PC species were secondary outcome variables. RESULTS:Choline supplementation increased plasma choline to near-fetal concentrations [35.4 (32.8-41.7) µmol/L vs. 17.8 (16.1-22.4) µmol/L, p < 0.01] and decreased D9-choline enrichment of PC. Single DHA treatment decreased DHA in PC relative to total lipid [66 (60-68)% vs. 78 (74-80)%; p < 0.01], which was prevented by choline. DHA alone increased DHA-PC only by 35 (26-45)%, but combined treatment by 63 (49-74)% (p < 0.001). D9-choline enrichment showed preferential synthesis of PC containing linoleic acid. PC synthesis via phosphatidylethanolamine methylation resulted in preferential synthesis of DHA-containing D3-PC, which was increased by choline supplementation. CONCLUSIONS: 30 mg/kg/day additional choline supplementation increases plasma choline to near-fetal concentrations, dilutes the D9-choline tracer via increased precursor concentrations and improves DHA homeostasis in preterm infants. TRIAL REGISTRATION: clinicaltrials.gov. Identifier: NCT02509728.
RCT Entities:
OBJECTIVE:Choline and docosahexaenoic acid (DHA) are essential nutrients for preterm infant development. They are metabolically linked via phosphatidylcholine (PC), a constitutive plasma membrane lipid and the major transport form of DHA in plasma. Plasma choline and DHA-PC concentrations rapidly decline after preterm birth. To improve preterm infant nutrition, we evaluated combined compared to exclusive choline and DHA supplementation, and standard feeding. DESIGN: Randomized partially blinded single-center trial. SETTING: Neonatal tertiary referral center in Tübingen, Germany. PATIENTS: 24 inborn preterminfants < 32 week postmenstrual age. INTERVENTIONS: Standard nutrition (control) or, additionally, enteral choline (30 mg/kg/day), DHA (60 mg/kg/day), or both for 10 days. Single enteral administration of 3.6 mg/kg [methyl-D9-] choline chloride as a tracer at 7.5 days. MAIN OUTCOME MEASURES: Primary outcome variable was plasma choline following 7 days of supplementation. Deuterated and unlabeled choline metabolites, DHA-PC, and other PC species were secondary outcome variables. RESULTS:Choline supplementation increased plasma choline to near-fetal concentrations [35.4 (32.8-41.7) µmol/L vs. 17.8 (16.1-22.4) µmol/L, p < 0.01] and decreased D9-choline enrichment of PC. Single DHA treatment decreased DHA in PC relative to total lipid [66 (60-68)% vs. 78 (74-80)%; p < 0.01], which was prevented by choline. DHA alone increased DHA-PC only by 35 (26-45)%, but combined treatment by 63 (49-74)% (p < 0.001). D9-choline enrichment showed preferential synthesis of PC containing linoleic acid. PC synthesis via phosphatidylethanolamine methylation resulted in preferential synthesis of DHA-containing D3-PC, which was increased by choline supplementation. CONCLUSIONS: 30 mg/kg/day additional choline supplementation increases plasma choline to near-fetal concentrations, dilutes the D9-choline tracer via increased precursor concentrations and improves DHA homeostasis in preterm infants. TRIAL REGISTRATION: clinicaltrials.gov. Identifier: NCT02509728.
Authors: Lotte Smolders; Nicole J W de Wit; Michiel G J Balvers; Rima Obeid; Marc M M Vissers; Diederik Esser Journal: Nutrients Date: 2019-11-13 Impact factor: 5.717
Authors: K A Böckmann; A von Stumpff; W Bernhard; A Shunova; M Minarski; B Frische; S Warmann; E Schleicher; C F Poets; A R Franz Journal: Eur J Nutr Date: 2020-05-31 Impact factor: 5.614
Authors: Anna Shunova; Katrin A Böckmann; Michaela Minarski; Axel R Franz; Cornelia Wiechers; Christian F Poets; Wolfgang Bernhard Journal: Nutrients Date: 2020-12-13 Impact factor: 5.717
Authors: Kevin C W Goss; Victoria M Goss; J Paul Townsend; Grielof Koster; Howard W Clark; Anthony D Postle Journal: Am J Clin Nutr Date: 2020-12-10 Impact factor: 7.045
Authors: Wolfgang Bernhard; Marco Raith; Anna Shunova; Stephan Lorenz; Katrin Böckmann; Michaela Minarski; Christian F Poets; Axel R Franz Journal: Nutrients Date: 2022-02-08 Impact factor: 5.717